Purchases and Sales Made in Q3 2022 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q3 2022. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
21.2KNew |
$49.5K - $84.9K
|
21.2K
$38.6K
|
|
|
Oct 13, 2022
Q3 2022
|
Activest Wealth Management
|
BUY
|
- |
7.6KNew |
$17.7K - $30.4K
|
7.6K
$13.8K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
4.89KNew |
$11.4K - $19.6K
|
4.89K
$8.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
605+ 10.81% |
$1.41K - $2.42K
|
6.2K
$11.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
1+ 0.0% |
$2.33 - $4
|
288K
$524K
|
|
|
Nov 10, 2022
Q3 2022
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
- |
1New |
$2.33 - $4
|
1
$1.82
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-2- 0.81% |
$4.66 - $8
|
246
$448
|
|
|
Nov 10, 2022
Q3 2022
|
Envestnet Asset Management Inc
|
SELL
|
- |
-477- 3.91% |
$1.11K - $1.91K
|
11.7K
$21.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-741- 9.59% |
$1.73K - $2.96K
|
6.99K
$12.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-3.93K- 9.51% |
$9.15K - $15.7K
|
37.4K
$68K
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-7.55K- 20.85% |
$17.6K - $30.2K
|
28.6K
$52.1K
|
|
|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-22.2K- 8.28% |
$51.7K - $88.8K
|
246K
$448K
|